Skip to main content
. 2020 Aug 11;184(1):23–35. doi: 10.1007/s10549-020-05782-4

Fig. 3.

Fig. 3

PALOMA-3: STEPP Analyses Evaluating PFS Effect. a Patients who received adjuvant therapy, b patients who received adjuvant therapy and had visceral metastases, and c patients who received adjuvant therapy and had nonvisceral metastasesa. CI confidence interval, DFI disease-free interval, PFS progression-free survival, STEPP subpopulation treatment effect pattern plot. aDFI was defined as the time between the first diagnosis of breast cancer and disease recurrence in PALOMA-3